An international team of researchers published an article (“Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia”) in the Journal of Leukocyte Biology that reportedly reveals that certain protein markers may indicate which patients have stable forms of CLL and which have more aggressive types.
Since early last March, around 1,000 organisations supporting clinical trials as a sponsor, collaborator or contract research organisation (CRO) have announced disruptions to planned and ongoing clinical trials. Companies have delayed the initiation of planned trials or withdrawn them completely, have suspended enrolment in ongoing trials, or have terminated these trials. GlobalData tracks these disrupted trials and organisations, along with trials that have resumed activity since disruption.